You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
chart
Support
Support
+
-
deaf
Search
ع
Home
Ministry
About the Ministry
- Overview
- Health Indicators
- Organizational Structure
- Strategies, Policies and SLA
- Budget and Expenditure
- Tenders and Procurement
- Partnerships
- Work For Us
- Contact Us
- Sustainable Development
- Help & Support
- Open Data
About the Minister
- Minister’s CV
- Minister's Office
- Contact the Minister
Patient Satisfaction Survey Results
Regulations
Forms
Anti-Discrimination Policy
Unified Health File
MOH Initiatives & Projects
Knowledge Management
National E- Health Strategy
Life Events
About MOH Portal
e-Participation
Interactive Map
Awareness
Patients’ Rights
Educational Content
- First Aid
- Chronic Diseases
- Health Tips
- Healthy lifestyle
- Oral Health
- Educational Series
- Seasonal and Festival Health
- Child’s Health
- Women's Health
- Various Topics
- Elderly’s Health
Health Tools
- BMI Calculator
- IBW Calculator
- Calorie Calculator
- Best Time To Get Pregnant
- Pregnancy Due Date Calculator
- Visual Acuity Test
- Prediabetes Risk Test
- Asthma Control Test
World Health Days
Premarital Screening
Pilgrim’s Health
E-Services
Media Center
MOH News
MOH Announcements
Events and Activities
MOH Publications
Important Links
E-Participation
Sign In
Sign In
MOH Portal
PHOC
Public health events and alerts
International Events
International Events
Listen
Facts on Omicron XBB.1.5 variant
Page Image
Image Caption
Page Content
January 15, 2023
Facts:
The XBB.1.5 strain is a mutated version of Omicron XBB, which was first detected in India in August. XBB, which is a merger of variants BJ.1 and BA.2.75, caused cases to quadruple in just one month in some nations.
The XBB.1.5 is a recombinant of the omicron BA.2.10.1 and BA.2.75 subvariants and was first detected in India and reached to 74 countries according to outbreak.info.
It has raised concerns about another potential wave of Covid cases following the busy holiday travel season.
Combined, XBB and XBB.1.5 make up 44% of cases in the USA., more than other versions of Omicron.
About 75% of confirmed cases are reported to be XBB.1.5 in the northeast of the USA. It appears to be spreading quickly but there’s no indication it causes more severe illness than any other Omicron virus.
One of the UK's largest Covid surveillance centers (Sanger Institute) shows 4% of cases in the week to December 17 were caused by XBB.1.5.
Scientists worry that XB.1.5 can get around the antibodies we have built up from Covid vaccines and previous infection from the many different types of Omicron that have spread since last December, including the original BA.1 and the more recent BQ.1.1 and BQ.1 subvariants.
XBB.1.5 has gained mutations, including F486P, which help it to bypass Covid-fighting antibodies that were generated in response to vaccination or previous infection. Another change S486P is thought to improve its ability to bind to cells.
New Covid boosters from Moderna and Pfizer-BioNTech bolstered antibody responses to many subvariants of Omicron, including the XBB variant.
References:
Centers for Diseases Control and Prevention
NBC News, Covid19
Mail Online, Variant XBB.1.5
in this
Section
International Events
Currently selected
Also
You may be interested
Last Update :
25 January 2023 11:57 PM
Reading times :
Public health events and alerts
COVID-19
2020
International Events
Currently selected
International Events
Monkeypox
Ebola Virus Disease Outbreak in Democratic Republic of the Congo
Crimean-Congo Hemorrhagic Fever Outbreak in Iraq
Marburg Virus Disease
Pakistan Floods and Its Potential Impact on International Public Health
Circulating Vaccine-Derived Polio Virus Type 2
Ebola Virus Disease in Uganda and the Democratic Republic of Congo
Outbreak of Rift Valley Fever in Mauritania
Dengue Fever Outbreak in Nepal
Cholera Outbreak in Haiti
Cholera Outbreak in Lebanon
Malaria Outbreak in Pakistan
Update on Covid19 variants of interest (VOI) and variants of concern (VOC)
Epidemiological Situation of COVID-19 Disease in the Republic of China
Influenza Pandemic in The World
Impact of COVID-19 Vaccines on Disease Evolution
Rates of Scarlet Fever and Group A Streptococcal Infection Increased in Several Countries
Facts on Omicron XBB.1.5 variant
Update of Epidemiological Situation of Cholera Globally
Bivalent Covid-19 Vaccine
Local Events
Middle East Respiratory Syndrome (MERS)
2018
2019
2020
2021
Monkeypox
2022
2023
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.